Список литературы (часть 4)

16.01.2012г.

Сулиндак

Brogden R. H., Heel R. C., Speight Т. М., Avery G. S. Sulindac: A review of its pharmacological properties and therapeutic efficacy in rheumatic diseases. — Drugs, 1978, 16, 97.

Duggan D. E., Hare L. E., Ditzler С A. et al. The disposition of sulindac. — Clin. Pharmacol. Therapeutics, 1977, 21, 326.

Huskisson E. C., Franchimont P. Clinoril in the Treatment of Rheumatic Disorders (Raven Press, New York, 1976).

Miller 7. L. Marrow apla ia with sulindac.  — - Ann. inter. Med., 1980, 92, 129.

Sanz M. A., Martinez 7. A., Gomis F., Garcia-Borras 7. 7. Sulindac induced bone marrow toxicity. — Lancet, 1980, 2, 802.

Special symposium on sulindac. Woridwide perspective. — Europ J. Rhematol. Inflammation, 1978, 1, 6.

Мефенамовая кислота

Mason R. M., Barnardo D. E., Fox W. R., Weatherall M. Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin. — Ann. rheumat. Dis., 1967, 26, 373.

Флуфенамовая кислота

Brooks P. M., Buchanan W. W. Buchanan and Dick (Eds.) Recent Advances in Rheumatology. Part 2, p. 54. Churchill Livingstone, Edinburgh, 1976.

Holmes E. L. Fenamates in medicine. — Ann. physic. Med., 1967, 36, Suppl.

Rajan К. Т., Hill A. G. S., Barr A., Whitwell E. Flufenamic acid in rheumatoid arthritis. — Ann. rheumat. Dis., 1967, 26, 43.

Simpson M. R., Simpson N. R. W., Masheter H. C. Flufenamic acid in rheumatoid arthritis. Comparison with aspirin and the results of extended treatment. — Ann. physic. Med., 1966, 8, 208.

Диклофенак

Brogden R. N., Heel R. C., Pakes G. E. et al. Diclofenac sodium: A review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. — Drugs, 1980, 20, 24.

Doreen M. S., Boardman P. L., Fowler P. D., Poole P. H. Diclofenac in rheumatoid arthritis, — Rheumatism and Rehabilitation, 1978, 17, 95.

Fowler P. D. Voltarol: diclofenac sodium; in Huskisson (Ed.) Clinics in Rheumatic Diseases, vol. 5. Antirheumatic Drugs, p. 427. Saunders, London, 1979.

Ghazi S. A., Fowler P. D. A clinical trial of a new anti-inflammatory analgesic compound in rheumatoid arthritis. — J. intern. Med. Res., 1973, 1, 591.

John V. A. Diclofenac (Voltarol) in the treatment of rheumatic diseases: A conspectus of international experience. — Rheumatology and Rehabilitation, 1979,22 (Suppl.), 22.

Krupp P. J., Menasse-Gydnja R., Sallman A. et al. Sodium 0-/2,6-dichlorophe-nyl)-amino/-phenyl-acetate (GP45, 840), a new non-steroidal anti-inflammatory agent. — Experienta (Basle), 1973, 29, 450.

Ku E. C, Wasvary 7. M., Cash W. D. Diclofenac sodium 450 (GP45i, 840) a potent inhibitor of prostaglandin synthetase. — Biochem. Pharmacol., 1975, 24, 641.

Riess W., Stierlin H., Degan P., Faigle 7. W. et al. Pharmacokinetics and meta-rJ?1^1?^ ° ^е anti-inflammatory agent voltaren. — Scand. J. rheumat., 1978 (Suppl. 22), 17.

Фенклофенак

A seminar of fenclofenac. Proceedings of the Royal Society of Medicine, 1977, 70 (Suppl. 6).

Berry H., Ford-Hutchinson A. W., Camp Am V. et al. Antirheumatic activity of fenclofenac. — Ann. rheumat. Dis., 1980, 39, 473.

Fenclofenac in Arthritis. Royal Society of Medicine and Academic Press, London, 1980.

Ratcliffe W. A., Hazelton R. A.f Thomson J. A. The effect of fenclofenac on thyroid function tests in vivo and in vitro. — Clin. Endocrinol., 1980, 13, 569.

Tudor R., Goldberg A. A. J., Clarke D. R. Fenclofenac: Techniques involved in the definition of therapeutic dose range. XIV International Congress of Rheumatology, San Francisco. XIV International Congress of Rheumatology, California, 1977.

Пироксикам

Brogden R. N.3 Heel R. C, Speight Т. М., Avery G. S. Piroxicam: A review of its pharmacological properties and therapeutic use. — Drugs, 1981, 22, 3.

Wiseman E. H., Boyle J. A. Piroxicam (Feldene) in Huskisson (Ed.) Clinics in Rheumatic Disease, Antirheumatic Drugs 11 p., 585. Saunders, London, 1980.

Зомепирак Zomepirac. — J. clin. Pharmacol., 1980, 20 (Part 2), 373.

Холин-магний трисалицилат

Mlechamn W. J., Lechner B. L. Clinical comparative evaluation of choline magnesium trisalicylate and acetylsalic lie acid in rheumatoid athritis. — Rheumatology and Rehabilitation, 1979, 18, 19.

Cohen A., Garber H. E. Comparison of choline magnesium trisalicylate and acetylsalic lie acid in relation to fecal blood loss. — Curr. Therapeutic Res., 1978, 23, 187.

Ehrlich G. E., Miller S. В., Zeiders R. S, Choline magnesium trisalicylate versus ibuprofen in rheumatoid arthritis. — Rheumatology and Rehabilitation, 1980, 19, 30.

Zucker M. В., Rothwell K. G. Differential influences of salicylate compounds on platelet aggregation and serotonin release. — Curr. Therapeutic Res., 1978,23,194.

Фентиазак

Some epidemiological, social and therapeutic aspects of rheumatology. — Curr. med. Res. Opinion, 1979, 6, (Suppl. 2).

Индопрофен

Bruni G., Groppi W., Fanfani A., Sacchetti G. Indoprofen: A review of human studies; in Huskisson (Ed.) Clinics in Rheumatic Diseases Antirheumatic Drugs 11. Saunders, London, 1980.

Huskisson E. C, Scott J. Analgesic and anti-inflammatory properties of indoprofen. — Rheumatology and Rehabilitation, 1979, 18, 49.

Indoproten. Controlled Clinical Trials. Groppi, Dellantonio, Bergamini and Verg-nano (Eds.). Farmitalia Carlo Erba S. p. A., Milan, 1979.

Проказон и флупроказон

Broil H., Eberl R., Tausch G. Proquazone in the treatment of rheumatoid arthritis. — Curr. Therapeutic Res., 1978, 23, 27. Proquazone — Scand. I. Rheumatol., 1978 (Suppl. 21).

Тиапрофеновая кислота

Daymond Т. J., Thompson M., Akbar F. A., Chestney V. A controlled trial of tiaprofenic acid versus ibuprofen in rheumatoid arthritis. — Rheumatology and Rehabilitation, 1979, 18, 257.

Pottier J., Berlin В., Raymond J. P. Pharmacokinetics of the anti-inflammatory tiaprofenic acid in humans, mice, rats, rabbits and dogs. — J. pharnu Sci., 1977, 66, 1030.

Орготеин Arrigoni-Martelli E. Orgotein — A review. — Drugs of Today, 1980, 16, 97.

«Лечение ревматических заболеваний»,
под ред. Ф.Д.Харта





Читайте далее: